Publication | Closed Access

MIL-1, a novel antitumor agent derived from natural product millepachine, acts as tubulin polymerization inhibitor for the treatment of hepatocellular carcinoma

OncologyHepatocellular CarcinomaMedicineImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyNatural Product MillepachineTumor MicroenvironmentCancer ResearchTubulin Polymerization Inhibitor